Cargando…
Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers
Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a cell–cell adhesion protein conferring heterotypic and homotypic interactions between cells of the same type and different types. It is aberrantly expressed in various cancer types and has been shown to be a regulator of cancer metastasis....
Autores principales: | Yang, Yi Ming, Ye, Lin, Ruge, Fiona, Fang, Ziqian, Ji, Ke, Sanders, Andrew J., Jia, Shuqin, Hao, Chunyi, Dou, Q. Ping, Ji, Jiafu, Jiang, Wen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821744/ https://www.ncbi.nlm.nih.gov/pubmed/36614319 http://dx.doi.org/10.3390/ijms24010876 |
Ejemplares similares
-
Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination
por: Sanders, Andrew J., et al.
Publicado: (2019) -
The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
por: Yang, Yiming, et al.
Publicado: (2021) -
Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018) -
Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
por: Hooker, R.A., et al.
Publicado: (2015) -
Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand
Publicado: (1995)